VolitionRx Limited
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.7M | $1.2M | $775.3K | $306.4K | $90.0K | $13.4K | $17.1K |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $10.1M | $14.4M | $19.6M | $15.3M | $13.0M | $14.5M | $10.4M |
| SG&A Expense | — | $9.5M | $8.5M | $10.4M | $10.2M | $11.7M | $5.7M | $4.7M |
| Operating Income | — | $-21.7M | $-27.0M | $-36.0M | $-31.8M | $-28.3M | $-21.2M | $-16.0M |
| Operating Margin | — | -1,258.5% | -2,190.9% | -4,641.8% | -10,372.4% | -31,469.0% | -158,176.2% | -93,840.2% |
| Interest Expense | — | — | — | — | — | $155.8K | $129.8K | $126.6K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-23.4M | $-27.0M | $-35.7M | $-30.6M | $-27.0M | $-20.4M | $-16.1M |
| Net Margin | — | -1,352.2% | -2,186.3% | -4,601.7% | -9,986.7% | -29,977.0% | -151,859.6% | -94,168.5% |
| EPS (Basic) | — | — | — | — | — | $-0.51 | $-0.45 | $-0.41 |
| EPS (Diluted) | — | — | $-0.31 | $-0.50 | — | $-0.51 | $-0.45 | $-0.41 |
| Shares Outstanding (Basic) | 8.1M | — | — | — | 57.9M | 53.8M | 48.6M | 41.1M |
| Shares Outstanding (Diluted) | 8.1M | 106.8M | 86.5M | 71.2M | 57.9M | 53.8M | 48.6M | 41.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |